Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
29.10. | MedCity FemFwd: How Doulas Can Improve Maternal Health Outcomes | ||
29.10. | Are You a Startup Looking for an Audience of Investors? We Have The Perfect Pitch Contest for You! | ||
29.10. | VBC, MA, FHIR and Modern Care | ||
29.10. | A CEO's Guide to AI Exploration: Transforming Organizations and Mindsets | ||
29.10. | AbbVie Adds Another Alzheimer's Prospect With $1.4B Aliada Therapeutics Acquisition | ||
28.10. | This Problem Keeps Hospital Execs Up at Night, Tampa General Hospital CEO Says | ||
28.10. | HealthJoy, Cost Plus Drugs Partner To Reduce Drug Costs for Employers | ||
28.10. | Novartis to Pay $150M for Monte Rosa Glue Drug in the Clinic for Immunology Indications | ||
28.10. | Harnessing AI in Pathology: A Vital Tool That Requires Careful Ownership | ||
28.10. | Increasing Efficiency and Reimbursements with Clearinghouses | ||
27.10. | Seaport Therapeutics Secures $225M for New Kind of Depression Drug | ||
27.10. | Navigating the Breast Cancer Screening Debate: The Role of AI and Precision Medicine | ||
27.10. | 7 Hot Takes I Heard at HLTH | ||
27.10. | NCQA's Updated 2025 Standards Have Published: What it Means for Quality and Compliance in Healthcare | ||
25.10. | CGMs Aren't Just for People with Diabetes Anymore, Dexcom COO Says | ||
25.10. | MedCity Pivot Podcast: Chat With Shawn Gremminger About Employer-Led Healthcare | ||
25.10. | Septerna's Upsized IPO Brings In $288M to Support a Pipeline of GPCR Drugs | ||
25.10. | The 3-Pronged Strategy to Boost Patient Engagement with Your CRM | ||
25.10. | Can Color Impact Healthcare Culture? | ||
25.10. | Gates Foundation Joins Radiant Bio's $35M Round for Antibody Drugs With 'Better Grip' | ||
24.10. | How To Spot Deepfakes and Other Cybersecurity Panel Takeaways from HLTH | ||
24.10. | 4 Things That Worry FDA Commissioner Robert Califf | ||
24.10. | Video: Was Carrum's CEO the Voice of Reason at HLTH? | ||
24.10. | The Convergence of Digital Health and Life Sciences | ||
24.10. | Targeting the Blast Radius: Why Spatial AI Diagnostics Are Crucial for Maximizing the Impact of Antibody-Drug Conjugates |